Document Detail

Endocardial Pacing: The Wave of the Future?
MedLine Citation:
PMID:  22825920     Owner:  NLM     Status:  Publisher    
Cardiac resynchronization therapy (CRT) is a proven treatment for heart failure and requires the implantation of a left ventricular (LV) lead, usually placed in a tributary of the coronary sinus. Encouraged by the fact that approximately 30 % of the patients receiving CRT do not benefit from this therapy, LV endocardial pacing has been proposed as an alternative to traditional LV transvenous epicardial pacing. Endocardial LV pacing has a number of potential advantages over conventional LV epicardial pacing, including a more physiological endocardial-to-epicardial transmural activation sequence, a faster ventricular activation, a larger choice of stimulation sites and a potential superior hemodynamic performance. On the other hand, cardiologists will have to deal with new implant techniques' (transseptal), higher risk of thromboembolic events, and challenging extraction procedures of infected material. The future of endocardial stimulation will depend on the results of randomized studies adequately powered to assess the feasibility, the safety and the effectiveness of this new pacing strategy.
Pierre Bordachar; Sylvain Ploux; Joost Lumens
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-7-24
Journal Detail:
Title:  Current cardiology reports     Volume:  -     ISSN:  1534-3170     ISO Abbreviation:  -     Publication Date:  2012 Jul 
Date Detail:
Created Date:  2012-7-24     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100888969     Medline TA:  Curr Cardiol Rep     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Bordeaux 2 University, Bordeaux, France,
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  A Primer on Arrhythmias in Patients with Hypertrophic Cardiomyopathy.
Next Document:  Insulin and IGF-I receptors in human cardiac microvascular endothelial cells; metabolic, mitogenic a...